Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy-Reference-Cited by-同舟云学术

Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy

Published:2020-10 Issue: Volume:143 Page:110100
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Tian Junjie,Fu Guanghou,Xu Zhijie,Chen Xiaoyi,Sun Junjie,Jin Baiye

Funder

Key Research and Development Program of Zhejiang Province

Publisher

Elsevier BV

Subject

General Medicine

Reference76 articles.

1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017

2. Molecular landscape of non-muscle invasive bladder cancer;Messing;Bladder Cancer,2018

3. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) – 2019 update;Babjuk;Eur Urol,2019

4. Primary, adaptive, and acquired resistance to cancer immunotherapy;Sharma;Cell,2017

5. Evolution of acquired resistance to anti-cancer therapy;Foo;J Theor Biol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning for metabolomics research in drug discovery;Intelligence-Based Medicine;2023

2. What the Microscale Systems “See” In Biological Assemblies: Cells and Viruses?;Analytical Chemistry;2021-11-23

3. The limitless applications of single-cell metabolomics;Current Opinion in Biotechnology;2021-10

4. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation;Biomedicine & Pharmacotherapy;2021-01